NCT03208868View on ClinicalTrials.gov

Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

NARecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 5, 2013

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Cirrhosis, Liver
Interventions
DIETARY_SUPPLEMENT

Leucine enriched essential amino acid (EEA/LEU)

Patient with cirrhosis will be randomized to either take a Leucine enriched essential amino acid or a balanced amino acid supplement.

DIETARY_SUPPLEMENT

Balanced amino acid supplement (BAA)

Patient with cirrhosis will be randomized to either take a Leucine enriched essential amino acid or a balanced amino acid supplement.

Trial Locations (1)

44195

RECRUITING

Cleveland Clinic Foundation, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER